{"transactions":[{"id":4617418,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:02.000Z","date":"2026-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":568,"price":84.37,"value":47922.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":19370.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991414/000122520826007812/doc4.xml","form_type":"4"}},{"id":4617417,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:02.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":355,"price":86.77,"value":30803.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":19938.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991414/000122520826007812/doc4.xml","form_type":"4"}},{"id":675430,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-08-26T22:00:29.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":1240,"price":91.465,"value":113416.6,"ownership":{"direct":true},"balance_after":20293.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007332/doc4.xml","form_type":"4"}},{"id":700925,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-30T21:30:50.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":146.3127,"price":86.0338,"value":12587.83756926,"ownership":{"direct":true},"balance_after":21533.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-006853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006853/doc4.xml","form_type":"4"}},{"id":702517,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":false,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9628,"derivative":{"exercise_price":74.02,"exercise_date":"2024-09-14","expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":9628},"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":702516,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"sale","planned":false,"acquired":false,"shares":9628,"price":85.06,"value":818957.68,"ownership":{"direct":true},"balance_after":21679.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":702515,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":true,"shares":9628,"price":74.02,"value":712664.56,"ownership":{"direct":true},"balance_after":31307.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":785474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Performance Rights","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":5200,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":26400,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":593,"price":79.73,"value":47279.89,"ownership":{"direct":true},"balance_after":21679.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":226,"price":82.76,"value":18703.76,"ownership":{"direct":true},"balance_after":22272.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785470,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":264,"price":83.2,"value":21964.8,"ownership":{"direct":true},"balance_after":22498.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":22762.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":978180,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-12-08T22:50:03.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":583,"price":86.01,"value":50143.83,"ownership":{"direct":true},"balance_after":17562.8708,"source":{"system":"sec-edgar","filing":"0001225208-25-009791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009791/doc4.xml","form_type":"4"}},{"id":1040909,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-09-15T22:42:44.000Z","date":"2025-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":650,"price":77.57,"value":50420.5,"ownership":{"direct":true},"balance_after":18145.8708,"source":{"system":"sec-edgar","filing":"0001225208-25-007990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007990/doc4.xml","form_type":"4"}},{"id":1040908,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2025-09-15T22:42:44.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":6410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on September 11, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":18795.8708,"source":{"system":"sec-edgar","filing":"0001225208-25-007990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007990/doc4.xml","form_type":"4"}},{"id":1154318,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Performance Rights","published_at":"2025-05-09T23:34:16.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":3350,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001225208-25-004945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004945/doc4.xml","form_type":"4"}},{"id":1154317,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:16.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":17100,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":17100},"source":{"system":"sec-edgar","filing":"0001225208-25-004945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004945/doc4.xml","form_type":"4"}},{"id":1154316,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:16.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":12349.1916,"source":{"system":"sec-edgar","filing":"0001225208-25-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004945/doc4.xml","form_type":"4"}},{"id":1154315,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:16.000Z","date":"2025-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":300,"price":74.92,"value":22476.0,"ownership":{"direct":true},"balance_after":8999.1916,"source":{"system":"sec-edgar","filing":"0001225208-25-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004945/doc4.xml","form_type":"4"}},{"id":1154314,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:16.000Z","date":"2025-05-07","kind":"sale","planned":false,"acquired":false,"shares":268,"price":75.0778,"value":20120.8504,"ownership":{"direct":true},"balance_after":9299.1916,"source":{"system":"sec-edgar","filing":"0001225208-25-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004945/doc4.xml","form_type":"4"}},{"id":1340942,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2024-12-06T21:56:45.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":583,"price":73.27,"value":42716.41,"ownership":{"direct":true},"balance_after":9493.8468,"source":{"system":"sec-edgar","filing":"0001225208-24-010630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010630/doc4.xml","form_type":"4"}},{"id":1407019,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2024-09-17T00:17:49.000Z","date":"2024-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":648,"price":68.52,"value":44400.96,"ownership":{"direct":true},"balance_after":10033.0463,"source":{"system":"sec-edgar","filing":"0001225208-24-008722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008722/doc4.xml","form_type":"4"}},{"id":1522375,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Performance Rights","published_at":"2024-05-09T23:36:54.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":3350,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001225208-24-005883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005883/doc4.xml","form_type":"4"}},{"id":1522374,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:36:54.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":17800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":17800,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":17800},"source":{"system":"sec-edgar","filing":"0001225208-24-005883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005883/doc4.xml","form_type":"4"}},{"id":1522373,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2024-05-09T23:36:54.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":10648.5547,"source":{"system":"sec-edgar","filing":"0001225208-24-005883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005883/doc4.xml","form_type":"4"}},{"id":1780465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-09-15T21:01:15.000Z","date":"2023-09-14","kind":"grant","planned":false,"acquired":true,"shares":19256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable annually in equal installments over a period of four years commencing one year after the grant date."}],"balance_after":19256,"derivative":{"exercise_price":74.02,"exercise_date":"2024-09-14","expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":19256},"source":{"system":"sec-edgar","filing":"0001225208-23-008962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008962/doc4.xml","form_type":"4"}},{"id":1780464,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"GM & SVP, Surgical"}}],"security":"Common Stock","published_at":"2023-09-15T21:01:15.000Z","date":"2023-09-14","kind":"grant","planned":false,"acquired":true,"shares":7262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested annually in equal installments over a period of four years commencing one year after the grant date."}],"balance_after":7262,"source":{"system":"sec-edgar","filing":"0001225208-23-008962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008962/doc4.xml","form_type":"4"}}]}